On April 15th, Click Therapeutics announced FDA marketing authorization of CT-132, a prescription digital therapeutic (PDT) for the preventive treatment of episodic migraine.
On April 9th, the World Health Organization (WHO) designated the European Campus Rottal-Inn (DIT-ECRI) at Deggendorf Institute of Technology in Germany as its collaborating center for digital health